Functional Ovarian Cysts - Treatment Overview
Most functional ovarian cysts are harmless, do not cause symptoms, and go away without treatment. When treatment is needed, treatment goals include:
- Relieving symptoms of pelvic pain or pressure.
- Preventing more cysts from developing by preventing ovulation (if recurrence is a problem). Treatment with birth control pills prevents ovulation.
Initial treatment
Because functional ovarian cysts typically go away without treatment within 1 to 2 menstrual cycles, your doctor may recommend a period of observation without treatment ( watchful waiting) to see whether your ovarian cyst gets better or goes away on its own. Your doctor will do another pelvic exam in 1 to 2 months to see whether the cyst has changed in size.
If an ovarian cyst doesn't improve in 1 to 2 menstrual cycles, your doctor may want to do more tests to be sure that your symptoms are not caused by another type of ovarian growth. Home treatment with heat and pain-relieving medicine can often provide relief of bothersome symptoms during this time.
Ongoing treatment
A functional ovarian cyst that persists through 2 to 3 menstrual cycles, has an unusual appearance on ultrasound, or causes symptoms may require treatment with either medicines or surgery.
- Your doctor may suggest that you try birth control pills for several months to stop more cysts from forming.
- Surgical removal of the cyst (cystectomy) through a small incision ( laparoscopy) may be needed if a painful functional ovarian cyst does not go away despite medical treatment. If a cyst has an unusual appearance on ultrasound or if you have other risk factors for ovarian cancer, your doctor may recommend surgical removal through a larger abdominal incision ( laparotomy) instead of by using laparoscopy.
What To Think About
Cysts after menopause. After menopause, ovarian cancer risk increases. This is why all postmenopausal ovarian growths are carefully checked for signs of cancer. Some doctors will recommend removing the ovaries (oophorectomy) when any kind of cyst develops on an ovary after menopause. But the trend in medicine seems to be moving away from surgery for small and simple cysts in postmenopausal women. In the five years after menopause, some women will still have functional ovarian cysts now and then. Some postmenopausal ovarian cysts, called unilocular cysts, which have thin walls and one compartment, are rarely linked to cancer. 1
WebMD Medical Reference from Healthwise
Functional Ovarian Cysts Topics
ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:
- · having a strong need to go to the bathroom right away (also called "urgency")
- · leaks or wetting accidents (also called "urinary incontinence")
- · having to go to the bathroom too often (also called "urinary frequency")
IMPORTANT SAFETY INFORMATION
You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


